The gene for the Light Chain fragment of Tetanus Toxin (LC) induces synaptic inhibition by preventing the release of synaptic vesicles. The present experiment applied this approach within the rat midbrain in order to demonstrate that LC gene expression can achieve functionally and anatomically discrete effects within a sensitive brain structure. The deep layers of the superior colliculus/deep mesencephalic nucleus (dSC/DpMe) that are located in the rostral midbrain has been implicated in fear-induced increase of the acoustic startle reflex (fear potentiated startle) but exists in close proximity to neural structures important for a variety of critical functions. The dSC/DpMe of adult rats was injected bilaterally with adenoviral vectors for LC, green fluorescent protein, or vehicle. Synaptobrevin was depleted in brain regions of adenoviral LC expression. LC gene expression in the dSC/DpMe inhibited the increase in startle amplitude seen with the control viral infection, and blocked context-dependent potentiation of startle induced by fear conditioning. Although LC gene expression reduced the absolute amount of cue-specific fear potentiated startle, it did not decrease percent potentiated startle to a cue, nor did it reduce fear-induced contextual freezing, nonspecific locomotor activity, or general health, indicating that its effects were functionally and anatomically specific. Thus, vector-driven LC expression inhibits the function of deep brain nuclei without altering the function of surrounding structures supporting its application to therapeutic neuromodulation. Gene Therapy (2006) 13, 942-952.
Introduction
Functional neurosurgeons have long applied precise brain lesions to the treatment of a variety of neurological disorders including Parkinson's disease, tremor, pain, epilepsy, and psychiatric disorder. 1 Over the past decade, lesions have been largely supplanted by Deep Brain Stimulation (DBS), which utilizes implanted electrodes to deliver focal electrical current to the brain at frequencies that appear to decrease neuronal function in the stimulated area. The latter is adjustable and not inherently destructive. DBS is currently approved by the FDA for the treatment of Parkinson's disease (PD), dystonia, and tremor. 2 Electrical stimulation is also widely applied to the control of chronic pain. Despite expanding applications of this form of focused neural inhibition, DBS therapy has limitations. The implanted devices are prone to malfunction, disconnection, and infection, in addition to requiring periodic surgical procedures for battery replacement. Our laboratory 3 and others 4 have explored the delivery of the glutamate decarboxylase gene as an approach to gene-based neural inhibition. This approach is currently being applied in the human subthalamic nucleus as a possible treatment for Parkinsonian symptoms. 5 It is possible that focused expression of the gene for the Light Chain fragment of Tetanus Toxin (LC) may provide an alternative strategy for gene-based inhibition in the central nervous system (CNS). Our laboratory has recently demonstrated that direct injection of a first-generation adenoviral vector expressing LC (AdLC) induces synaptic inhibition in spinal cord motor neurons. 6 LC expression resulted in the digestion of synaptobrevin (VAMP-1), a protein critical for synaptic vesicle docking. The time course of synaptic inhibition paralleled that of gene expression, which diminished over the second and third weeks after injection.
Because clostridial toxins normally act on the spinal motor apparatus, it is not surprising that expression in this location would disrupt motor function of the spinal cord. Nonetheless, broader application of LC gene expression to therapeutic neural inhibition depends on the demonstration that the stereotactic injection of LC vectors can inhibit the synaptic function of neurons other than spinal motor neurons in an anatomically discrete and accurate fashion. We chose the acoustic startle reflex as a means to address this question, because of its well-defined circuitry embedded within the brainstem. In particular, the deep layers of the superior colliculus/ deep mesencephalic nucleus (dSC/DpMe) play a critical role in facilitation of the acoustic startle reflex induced by fear conditioning. [7] [8] [9] Inactivation of the dSC/DpMe blocks the facilitation of startle response by conditioned fear, known as fear-potentiated startle. Our recent study demonstrates that this effect is site and function specific. 9 In other words, inactivation of the dSC/DpMe only blocks potentiated startle without interfering the other behaviors that are mediated by the adjacent areas such as freezing and spontaneous locomotor activity. Freezing and locomotor activity are mediated by the central gray [10] [11] [12] and the mesencephalic locomotor region (MLR), 1, 13, 14 respectively, which are located in close proximity to the dSC/DpMe. A control study demonstrates that inaction of the central gray has little effect on fear-potentiated startle but tend to reduce freezing. 9 In addition, inactivation of mesencephalic reticular formation (MRF) that is located lateral to the dSC/DpMe and essential to maintaining consciousness 15 does not affect fear-potentiated startle as well. These findings suggest that the dSC/DpMe is functionally discrete from the adjacent brain areas. Thus, if LC gene expression has discrete effects on neuronal function, stereotactic AdLC injection in the dSC/DpMe should disrupt the acoustic startle response without disrupting freezing, locomotor activity, and arousal function that are mediated by these adjacent areas.
To test this hypothesis, individual groups of rats underwent stereotactic intra-dSC/DpMe injections with vehicle, control vector (AdGFP), or AdLC and the effects of AdLC and AdGFP injections on baseline startle and on fear-induced potentiation of startle were measured. Immunohistochemistry and Western blots demonstrated a local reduction of VAMP-1 in the region of LC expression that was confined to the dSC/DpMe. In the first experiment, LC expression in the dSC/DpMe prevented a mild vector-induced increase in baseline startle, and created a slight but not statistically significantly reduction in startle baseline. As predicted by previous applications of the AdLC vector, this effect was transient. In the second experiment, LC expression blocked the context-dependent fear-potentiated startle. However, neither the cue-specific potentiated startle, contextual freezing, or spontaneous locomotor function were affected by the LC gene expression. No changes in the animals' general health or level of consciousness, as measured by spontaneous locomotor activity, were noted. Taken together, these results suggest that vectormediated VAMP-1 digestion can suppress the function of brainstem nuclei in an anatomically and functionally discrete fashion. Further, they support the existence of a critical synapse for startle regulation in the dSC/DpMe.
Results
Forty rats underwent bilateral stereotactic injection with 2 ml of vector solution (8 Â 10 7 PFU) or vehicle into the dSC/DpMe. Examination of the dSC/DpMe in both AdLC-and AdGFP-injected animals revealed no structural damage in comparison with vehicle-injected control animals. In contrast to vehicle injected control animals, a mild infiltrate was noted in the dSC/DpMe of adenovirally injected animals as previously described. 10 This transient inflammatory response has not previously been demonstrated to disrupt neuronal function in the spinal cord. 11 Dense GFP expression was noted in both glial and neuronal elements with transgene expression in both cell bodies and axonal processes (Figure 1) . The mean distribution of gene expression was 1.6 mm in diameter in the coronal plane and 1.4 mm in the rostrocaudal direction. Figure 1 demonstrates the composite distribution of anatomical injection targets in the dSC/ DpMe, an area which was described elsewhere previously. 9 Briefly, the deep SC/DpMe is confined to the area between the deep layer of the superior colliculus (DpWh and DpG) and the deep mesencephalic nucleus (DpMe) in the dorsoventral plane, and between the central gray and the MRF in the mediolateral dimension in the rostral midbrain. As depicted in Figure 1 , gene expression was contained within deep SC/DpMe without significant spread into midline or ventral and lateral nuclei. GFP expression was observed in the AdLC and AdGFP groups but was absent in the vehicle group. No significant difference in targeting error could be detected between the AdLC (X ¼ 0.33 mm, Y ¼ 0.27 mm, Z ¼ 0.35 mm) and AdGFP (X ¼ 0.25 mm, Y ¼ 0.32 mm, Z ¼ 0.43 mm) groups. Because histological analysis was performed 11 days after the injection, the injection cannula tracts were not reliably identified in any of the groups.
Previous work in our laboratory has demonstrated the digestion of VAMP-1 by the LC transgene. 6 However, in situ reduction of VAMP-1 has not previously been demonstrated in brain parenchyma. Immunohistochemistry for VAMP-1 was performed in sections identified to contain AdLC-or AdGFP-mediated gene expression. Sections were imaged using confocal microscopy to evaluate the comparative distribution of LC expression and VAMP-1. Figure 2a -c illustrate that VAMP-1 staining is relatively decreased in regions of high GFP expression in AdLC-but not AdGFP-or vehicle-injected animals. Of note, some VAMP staining colocalized to GFP expression in the AdLC group, suggesting that LC expression depletes VAMP rather than eliminating it. Quantitative Western blots were performed on the dSC/ DpMe slices of animals that received ipsilateral injections of either AdLC (AdLC-I) or AdGFP (AdGFP-I) and contralateral injections of vehicle (AdLC-C and AdGFP-C). Figure 2d confirms that VAMP is selectively depleted in the deep brain target of AdLC injection. These findings, together with previous findings that AdLC but not AdGFP gene expression is capable of VAMP-1 digestion, implicate the intraneuronal enzymatic activity of LC in the observed behavioral effects.
The behavior study includes two sets of experiments that assess AdLC infection on baseline startle and fearpotentiated startle. All experimental animals underwent baseline measurement (preinfection) of acoustic startle prior to intracranial injection (in the first experiment) or prior to fear conditioning followed by intracranial injection (in the second experiment). Animals were assigned to individual treatment groups based upon baseline startle, and each of the groups had equivalent mean startle amplitudes (e.g., in Figure 4b , the dark gray bar between the AdGFP and AdLC groups, P ¼ 0.98).
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In the first behavior experiment that assessed the change of baseline startle, animals were assigned to either bilateral AdGFP (n ¼ 8) or AdLC (n ¼ 8) injection. AdGFP injection caused a mild albeit significant increase in baseline startle that was tested 11 days after the injection (postinfection, Figure 3a , the black bar), as compared to the preinfection baseline (the light gray bar, t(7) ¼ 4.362, Po0.01, all P-values for t-test are two-tailed probabilities). LC expression prevented this increase and slightly, but not statistically significantly, reduced baseline startle (t(7) ¼ 1.888, P ¼ 0.10). The opposite effects on baseline startle by the AdGFP and the AdLC infections resulted in a significant difference in percent change from preinfection baseline between the two groups (F(1,15) ¼ 13.36, Po0.01). Half of each group was killed to permit analysis of gene expression and targeting. The remaining animals (n ¼ 8) were tested for recovery from vector-mediated VAMP depletion. As depicted in Figure  3b , the difference between AdGFP and AdLC groups was observed at postinjection day 6 (F(1,7) ¼ 7.869, Po0.03), and it gradually resolved on postinjection day 16 (F(1,7) ¼ 0.282, P40.05). A linear trends test for the three postinjection measures using GLM procedures revealed a significant recovery in startle amplitude in the AdLC-treated rats (F(1,3) ¼ 71.58, Po0.01), but not in the AdGFP group (F(1,3) ¼ 0.05, P40.05), confirming previous observations of the reversible character of LC-dependent synaptic inhibition.
In the second behavioral experiment, animals underwent fear conditioning prior to vector injection. Fear conditioning resulted in higher startle amplitudes in rats when they were returned to the fearful context (the startle cages) where they previously experienced footshocks. This increase is known as fear-induced, contextdependent potentiated startle. Figure 4a depicts the comparison of percent increase startle response in six different groups that underwent either vehicle, AdGFP, or AdLC dSC/DpMe injection with or without fear conditioning. Fear conditioning significantly augmented startle over the small increase observed after AdGFP injection (F(1,15) ¼ 4.926, Po0.05), indicating that the increase in startle response by fear conditioning is so high that it masks the small increase induced by AdGFP vector injection. However, no difference could be GFP expression 11 days after AdLC injection is superimposed on the left side of a stereotactic rat brain atlas to depict its location and spread. A composite illustrating the epicenters of expression in each animal is superimposed on the right side of the atlas (green ¼ AdGFP; red ¼ AdLC). Two AdGFP points are obscured by overlying AdLC targets. The photomicrograph of AdLC-mediated GFP expression is magnified below the atlas, along with enhanced magnification of select regions. GFP expression is depicted within cells with a variety of morphologies (left) and an axon terminal (right).
Gene-based superior colliculus synaptic inhibition Z Zhao et al detected between the fear-conditioned groups after fear conditioning (P40.05), suggesting that vector-dependent facilitation and contextual fear-dependent facilitation are neither additive nor synergistic. Finally, both forms of facilitation are blocked by LC expression. Indeed, no difference is observed between the AdLC groups with and without fear conditioning (P40.05), while AdLCconditioned group is significantly different from the AdGFP-conditioned group (Po0.05). Effective fear conditioning is confirmed by a typical freezing behavior that occurred in AdGFP control rats after fear conditioning, but not in AdGFP rats that had not undergone fear conditioning ( Figure 6 , Po0.001).
Within subject analysis of the groups that underwent conditioning further supports the observation that dSC/DpMe LC gene transfer blocks the expression of contextual fear. As demonstrated in Figure 4b , the postinfection startle (the light gray bar) was increased equally in the vehicle and the AdGFP groups, when compared to the preinfection startle, (t(7) ¼ 4.54, Po0.01 and t(7) ¼ 3.54, Po0.01, respectively). In contrast, the postinfection startle was lower than the preinfection in the AdLC group (t(7) ¼ À4.34, Po0.01). Two-way ANO-VA revealed a significant pre versus postinjection time effect (F(2,23) ¼ 14.71, Po0.001) and group by time interaction (F(2,23) ¼ 16.32, Po0.001) among the three groups, but not a group effect (F(2,23) ¼ 2.89, P40.05). Subsequent comparisons with the vehicle group by twosided Dunnett's test revealed a significant reduction of percent change from the preinfection baseline (the black bar) in the AdLC group (Po0.01), but not in the AdGFP group (P40.05).
Startle amplitude was increased further in rats when tested in presence of the light cue that was previously paired with footshocks during fear conditioning, known as cue-specific fear-potentiated startle. Figure 5 demonstrates the cue-specific potentiation of startle response that was measured by the difference of startle amplitude in the presence of the light cue (light tone trials, the light gray bar) versus that in the absence of the light cue (tone alone trials, the dark gray bar), and the percent potentiation of startle in the light tone trials from the tone alone trials (the dark bar). The startle response in the tone alone and the light tone trials was tested in the postinfection session only. In contrast to the blockade of context-dependent potentiated startle in the AdLCinjected animals, the cue-specific potentiated startle was spared with LC expression despite that AdLC infection resulted in an overall reduction of startle amplitudes both in the tone alone and in the light tone trials. As Gene-based superior colliculus synaptic inhibition Z Zhao et al demonstrated in Figure 5 , the startle amplitude in the light-tone trials was higher than in the tone-alone trials in all groups (t(7) ¼ 4.49, Po0.01, t(7) ¼ 4.95, Po0.01 and t(7) ¼ 6.30, Po0.001 for vehicle, AdGFP, and AdLC groups, respectively). Similarly, one-way ANOVA yielded no significant difference in percent potentiation among the three groups (F(2,23) ¼ 0.335, P40.05). Thus, while the magnitude of context-dependent startle potentiation induced by fear conditioning is reduced, evidence of cue-specific potentiation remains.
In order to demonstrate that AdLC's impact on the context-dependent potentiation of startle was functionally selective, fear-induced freezing and spontaneous locomotor activity were assessed. Freezing was calculated by percent reduction of contextual activity following fear conditioning as compared to preconditioning level. Contextual activity, which represents the animals' response to environmental cues, was defined as the mean level of activity in the first 5 min, measured for 200 ms in every 10 s, when animals were placed into the startle cages. In animals that had undergone fear-conditioning training, the contextual activity was remarkably suppressed when they returned to the startle cages where they previously received footshocks. In contrast, 'spontaneous locomotor activity,' an index of general motor function, is defined as the mean level of spontaneous activity across the entire startle test session. In this case, the activity was sampled for 200 ms in every 30 s starting from the onset of the first startle stimulus up to the end of the test session. Figure 6 depicts contextual freezing in AdGFP-treated rats that had no fear conditioning and all other rats that had undergone fear-conditioning training, tested 24 h after fear conditioning (postconditioning, the light gray bar) and 11 days after intracranial injection (postinjection, the black bar). While no freezing was observed in rats that did not have fear conditioning, clear contextual freezing existed in the animals trained with fear conditioning (Po0.001). Note, however, the freezing behavior remained unchanged in the trained rats over the 11-day period after injection (t(7) ¼ 1.210, P40.05; t(7) ¼ 0.320, P40.05; and t(7) ¼ 0.138, P40.05 for vehicle, AdGFP, and AdLC, respectively). The difference in freezing between the postconditioning and the postinfection (the black bar) was not significantly different among the three trained groups (F(2,23) ¼ 0.269, P40.05). These results indicate that LC expression in the dSC/DpMe has little effect on freezing, consistent with previous findings in our lab. 9 Figure 7 compares spontaneous motor function in animals before and after deep SC/DpMe injection. There was no overall difference in the levels of spontaneous locomotor activity between the pre-and the postinjection sessions among the three groups (F(2,23) ¼ 0.52, P40.05). In addition, ANOVA conducted on spontaneous locomotor activity revealed no treatment effect among the groups (F(2,23) ¼ 0.88, P40.05). Thus, no change in spontaneous locomotor activity could be ascribed to surgery or gene expression. Monitoring of general health revealed an initial reduction in postoperative food consumption among all animals, which resolved prior Gene-based superior colliculus synaptic inhibition Z Zhao et al to the evaluation of startle, freezing, and motor functions 11 days after surgery. Daily veterinary observation revealed no changes in respiratory function, general arousal level, or general health among these animals.
Discussion
The present experiment demonstrates that vectormediated LC expression can induce functionally specific inhibition of neural function in the brainstem. Stereotactic vector administration achieved gene expression in an anatomically discrete distribution. LC expression resulted in selective suppression of dSC/DpMemediated startle facilitation. While AdGFP injection into the dSC/DpMe caused a 50% increase in startle, the AdGFP-induced increase of startle was blocked by LC expression in the dSC/DpMe that also caused slight reduction of startle. In addition, fear conditioning resulted in remarkable context-dependent potentiation in startle superseding the mild facilitation of startle induced by AdGFP infection. Again, the context-dependent fear-potentiated startle was blocked by LC expression. In contrast, cue-specific potentiated startle was not affected by LC expression in the dSC/DpMe, although the overall magnitude of startle was reduced in the AdLC-treated rats due to a blockade of contextual conditioning. In distinction to these findings, neither Within-subject analysis of the conditioned groups before and after conditioning and vector injection reveals that startle amplitudes were significantly increased in rats 11 days after SC/DpMe injection of PBS or AdGFP when the rats returned to the startle cages where they previously experienced mild footshocks (preinfection versus postinfection, Po0.01, respectively). This increase in startle amplitude was absent in AdLC-treated animals (Po0.01). In addition, the percent change from the preinfection baseline in the AdLC group was significantly lower than the other two groups (Po0.01). Gene-based superior colliculus synaptic inhibition Z Zhao et al fear-induced contextual freezing, general locomotor function, nor animal health were affected by LC expression. Immunohistochemistry and Western blots revealed a focal reduction in VAMP-1 levels in regions of LC expression within the dSC/DpMe, consistent with the previous demonstration of in vitro time and concentration-dependent rat brain VAMP-1 digestion. 6 These findings suggest that LC mediated VAMP-1 digestion can achieve targeted neural inhibition.
LC is the enzymatically active fragment of Tetanus Toxin. The holotoxin is normally synthesized as an inactive polypeptide chain of B150 kDa that is released with bacterial lysis. The inactive single chain molecules are cleaved to form a di-chain molecule, consisting of the light chain (LC, B50 kDa) and the heavy chain (Hc, B100 kDa) molecules linked by a single disulfide bond. Hc is responsible for neuronal membrane binding and membrane penetration, 12 while LC acts as a zincdependent endopeptidase. 15 LC cleaves the single Gln-76-Phe-77 bond of VAMP-1. Cleavage of VAMP-1 disrupts neurotransmitter release through disruption of the vesicle docking complex, thus inhibiting neurotransmission. 13, 14 However, inadvertent release of LC should not pose a threat since this fragment is not capable of neuronal binding and uptake. The brainstem contains densely packed structures responsible for a variety of critical activities including the vegetative functions of the reticular activating system necessary to maintain a wakeful state and defensive reactions including freezing. The observation that LC expression failed to alter general locomotor function or freezing is consistent with the hypothesis that LC expression only affects the neurons in which it is expressed. Our previous work has demonstrated that neuronal LC expression is capable of digesting synaptobrevin in vitro. 6 Spinal cord LC expression resulted in hindlimb sensorimotor dysfunction localized by electrophysiology to the neuromuscular junction. Because of the binding and transport properties of Hc, the spinal motor system is the endogenous target of clostridial neurotoxins. However, because VAMP-1 plays a role in synaptic transmission throughout the nervous system, LC expression should be capable of inhibiting neural function at multiple sites within the nervous system. Tetanus holotoxin causes spastic paralysis through a primary action on inhibitory spinal interneurons. 16, 17 Thus, initial experiments in the spinal cord suggested that LC's activity could be redirected through neuronal expression. In the present experiment, confocal microscopy and Western blots revealed reduced VAMP-1 levels in brain tissue expressing LC, supporting the hypothesis that LC is capable of neural inhibition in structures that are normally unaffected by the holotoxin. The confocal microscopy results further reinforce the notion that VAMP-1 digestion occurs in an anatomical area restricted to the region of gene expression. The absence of VAMP-1 reduction outside the region of LC expression is likely to Figure 6 LC expression in the dSC/DpMe does not prevent context-dependent freezing. In comparison with the contextual activity in rats undergoing no fear-conditioning training, fear conditioning results in a suppression of spontaneous motor activity when animals are returned to the startle cage where they previously received footshocks. This typical response to fearful environment is termed 'contextual freezing.' As no freezing existed in the postinfection test session in the untrained AdGFP-injected animals, contextual freezing were observed in all groups that were trained with fear conditioning (Po0.001). The light-gray and dark-gray bars, respectively, represent percent of contextual freezing tested 24 h after fear conditioning (postconditioning) and 11 days postinjection (postinfection). Note that contextual freezing remained unchanged over the 11 day period in all groups. The black bar represents the difference in freezing between the postconditioning and postinfection measurements. LC expression in the dSC/ DpMe did not alter the freezing behavior (P40.05). Gene-based superior colliculus synaptic inhibition Z Zhao et al underlie the functionally specific affects observed with expression in the deep SC/DpMe. The preponderance of existing data indicates a critical role of the dSC/DpMe in the neural circuit in the brain that modulates the startle response. This neural circuit originates from the amygdala and runs through distinct nuclei in the brainstem, where the dSC/DpMe serves as a relay between the extended amygdaloid complex and the primary startle pathway in the brainstem. 9 Inactivation of this nucleus by GABA agonists or AMPA antagonsits blocks the facilitation of startle response that is dependent on the extended amygdaloid complex such as fear-potentiated startle 8, 9 and light enhanced startle (our unpublished data). The findings in the present study that the context-dependent potentiation of startle was blocked by LC expression in the dSC/DpMe confirm the role of this nucleus in modulating fear-facilitated startle response. However, the limited effect of LC expression on cue-specific potentiation of startle is inconsistent with the previous findings. Currently, the mechanism is unclear. One of the possibilities is that some neurons in this area may have been spared from the LC infection. As the cue-specific fear is overwhelmingly more powerful than the context-dependent one, indicated by higher startle amplitude in presence of the light cue than in absence of the light cue, activation of the spared neurons by fear to the light cue may be sufficient to elicit an increase of startle, even though the overall levels of startle are reduced. Nevertheless, these results are also consistent with a parallel VAMP-1-independent circuit in the dSC/DpMe underlying cue-specific potentiation of startle.
It is arguable that the mild increase of startle in the AdGFP-treated animals may have resulted from surgery itself since pain and discomfort from surgery may increase the anxiety level in animals. However, similar surgery in the midbrain either fails to change startle or create a minor reduction of startle attributed to habituation, a behavioral mechanism for reducing response to repeated stimuli (unpublished data). Because mild inflammatory reactions were observed in the virusinfected animals, but not the vehicle ones, it is possible that the inflammation enhanced neural activity in the dSC/DpMe, and thus increased excitatory drive to the startle pathway. The frequent association of viral encephalitis with seizure activity supports the connection of inflammation with enhanced neural activity. We believe that under normal physiological conditions, the dSC/DpMe does not provide a tonic excitatory drive to the startle pathway because inactivation of the dSC/ DpMe by muscimol had little effect on baseline startle. 7 We hypothesize that viral-induced inflammation increases excitatory drive from the dSC/DpMe to the startle pathway. Thus, blockade of this increased excitatory drive by LC expression would inhibit the infection-dependent increase of startle as well as contextdependent facilitation. While a variety of mechanisms could be invoked to explain this connection, the reason for the effects of AdGFP and AdLC on baseline startle was not explored in the present experiments.
The absence of changes in freezing supports the idea that freezing is not mediated by the dSC/DpMe, confirming our previous report. 9 Together with no change of locomotor function, general health, and alertness in animals injected with AdLC in the dSC/ DpMe, the findings of the current study suggest LC expression in the brainstem can induce neuronal inhibition in a functionally discrete fashion.
In order for LC expression to constitute a feasible stereotactic therapy, it must provide some advantage over simple radiofrequency lesions. Stereotactic brain lesions continue to be applied to the treatment of pain, movement disorders, and certain psychiatric diseases. However, lesioning techniques have been largely supplanted by the implantation of electrodes, which provide a means of controlled and nondestructive modulation of neural function. 2 For gene-based neuromodulation to supplant implanted electrodes, the technique must be similarly nondestructive and controllable. Our previous work documented both neuronal survival and functional recovery following LC expression, suggesting that the observed functional inhibition results from the disruption of synaptic vesicle docking rather than neuronal death. However, despite the fact that first-generation adenoviral gene expression in the spinal cord is transient, 11 some investigators have suggested that expression by this vector in the brain may be sustained. 10 Despite these data, in the current experiment, LC gene mediated suppression of vector-related startle facilitation resolved on the same postinjection day at which spinal cord LC expression resolved. Gene expression as detected by GFP expression was substantially diminished in experimental animals. Thus, the results of the current study are adequate to prove the principle that functionally and neuroanatomically discrete neural inhibition can be achieved in the brain without neuronal death. Nonetheless, clinical application will require sustained and reliably inducible expression.
Materials and methods

Vector design
The synthesis of AdLC is described elsewhere in depth. 6 In short, the 1496 bp synthetic gene encoding the light chain of tetanus toxin protein (LC) was cloned into a shuttle vector between the CMV promoter, and an IRES-GFP sequence. AdLC was produced through Cremediated in vitro recombination. 18 AdGFP used as a control vector contains the gene for GFP under the control of a CMV promoter.
Animal surgery
Male Sprague-Dawley rats (Charles River, Raleigh, NC, USA), weighing 400-425 g at the time of surgery, were used in this study. Animals were housed in groups of four in plastic cages and maintained on a 12-h light-dark cycle (light 0700-1900 hours) with food and water available ad libitum. This work was carried out under conditions consistent with the US Department of Agriculture, Emory University, and National Institutes of Health rules for the care and use of laboratory animals and rules of biosafety. Under sodium pentobarbital anesthesia (50 mg/kg, i.p.), each animal was stereotactically injected with AdLC, or AdGFP (8 Â 10 7 PFU), or PBS at rate of 0.2 ml/min for 10 min for a total 2 ml of solutions. An additional 5 min were given for solution diffusion. The injection needle was then slowly removed over 5 min to prevent backup leaking of the solution along the track of the injection needle. The coordinates Gene-based superior colliculus synaptic inhibition Z Zhao et al for the deep SC/DpMe were AP ¼ À6.6 mm, ML ¼ 71.5 mm and DV ¼ À5.0 mm with respect to bregma and dura. After surgery, animals were closely observed for any changes of body weight, food consumption, and general health condition.
Startle apparatus
The details of startle apparatus were described elsewhere previously. 9 Briefly, rats were trained and tested in four identical startle cages located in separate chambers (90 Â 70 Â 70 cm) that were dark, ventilated, and sound attenuated. The floor of each cage consisted of four stainless steel bars (6 mm in diameter and 18 mm apart), through which a 0.5-s, 0.4 mA footshock was delivered. An accelerometer (PCM Piezotronics, Depew, NY, USA) was affixed to the bottom of the cage to detect any movement of the cage, which was used to measure startle response and spontaneous activity. The displacement of the accelerometer caused by cage movement generated voltage that was integrated and proportional to the velocity of cage movement. The analog output of the accelerometer was amplified, digitized, and recorded in a Macintosh G3 computer. Startle response was elicited by a 50-ms white-noise burst generated by the Macintosh G3 computer (0-22 kHz) and delivered through a high-frequency speaker (Radio Shack Supertweeters), positioned 5 cm from the front of each of the startle cages. A background white noise (60 dB) was otherwise constantly delivered through the same speaker. A visual conditioned stimulus (cue) was also delivered during fear-conditioning training. The visual cue was a 3.7-s light (70 lux) produced by an 8 W fluorescent bulb that was located 15 cm behind each startle cage. The presentation and sequencing of all stimuli were under the control of the Macintosh G3 computer using specially designed software (The Experimenter, Glassbeads Inc., Newton, CT, USA).
Behavioral assessments
There were two sets of experiments in this study to assess AdLC virus infections on either baseline startle or fear-induced increase of startle. In the first behavioral experiment that assessed the effects of virus infection on baseline startle, rats were given two sessions of matching on two consecutive days. During each of the matching sessions, animals were placed in the startle cages for 5 min without exposure to acoustic startle stimuli, during which contextual activity was sampled for 200 ms every 10 s. Immediately after, animals were given 15 startle eliciting stimuli (leaders) in a pseudorandom order, five at each of three different intensities (95, 100, and 105 dB) at a 30-s interstimulus interval (ISI). The leaders were used to familiarize the rats to the acoustic stimuli and were not used for statistical analysis. Following the leaders, another 30 startle stimuli were presented, 10 at each of the three different intensities with 30-s ISI. During the time between each of startle stimuli, spontaneous locomotor activity was sampled for 200 ms starting from the first of the 30-startle stimuli up to the end of the test session. The matching sessions were designed to produce some habituation and stabilization of the startle response and used to quantify baseline startle. The startle response in the last session of matching was used as the preinfection baseline startle. Animals were distributed between individual experimental groups in order to 'match' baseline startle levels such that each of the groups had equivalent mean startle amplitudes.
After 48 h, rats were given surgery for intracranial injection of AdGFP or AdLC in the procedure described above. Following 11 days of recovery from surgery, rats were returned to the startle cages and tested for baseline startle (postinfection test) in the procedure identical to the matching sessions. Immediately after the postinjection test session, half of the rats were killed and the brain was removed for immunohistochemical study. The remaining animals (n ¼ 4 in each group) were repeatedly tested for baseline startle on postoperative day 6 (postday 6), day 11 (post-day 11), and day 16 (post-day 16) to assess the functional recovery from the virus infection.
In the second experiment that assessed the effect of the virus infection on fear-induced potentiation of startle, the procedure was identical to the first experiment except that 24 h following the last session of matching, rats underwent two sessions of fear-conditioning training, one on each day, and one session of a short test of cuespecific fear-potentiated startle, and the surgery was performed immediately after the short test session. During each session of the training, rats were given 10 pairings of light cue and electric shock that consisted of a 3.7-s light and a 0.5-s, 0.4 mA footshock coterminating simultaneously. The mean intertrial interval (ITI) was 3 min (range 2-4 min). After 24 h, rats were given a short test to assess the success of fear-conditioning training (postconditioning). During the short test session, the contextual activity of rats were sampled once every 10 s for 5 min without exposure to any acoustic stimuli, followed by 15 leaders identical to the matching sessions. Then, five 95-dB startle stimuli in absence of light cue and another five startle stimuli in presence of light cue were given in a pseudorandom order. An increase of startle response in presence versus absence of the light cue was considered as successful training. Rats were divided into three groups using the startle amplitudes of the second matching session and the startle amplitudes of the short test session such that each of the groups had equivalent mean startle amplitudes of the matching and short test sessions. Following the short test session, animals underwent intracranial injected with vehicle, or AdGFP, or AdLC. After 11 days of recovery, rats were returned to the startle cages and tested for the change of startle response after fear conditioning and infection (postinfection). In the postinfection test session, contextual activity was sampled once every 10 s for the first 5 min when rats were returned to the startle cages and then 15 leader stimuli were presented, identical to the matching sessions. Immediately after the leaders, there were 30 startle stimuli in the presence of light cue (lighttone trial) and 30 stimuli in absence of light cue (tonealone trial), 10 at each of the three intensities (95, 100, 105 dB) with a 30-s ISI in a balanced, pseudorandom order. Between each of the 60-startle stimuli, the spontaneous locomotor activity was sampled across the entire test session, with the same method applied in the matching sessions. Locomotor activity sampled after the tone-alone trials were used as the postinfection locomotor activity.
Between subject comparison of conditioned and nonconditioned groups was based on data taken from both experiments. Because the first experiment did not Gene-based superior colliculus synaptic inhibition Z Zhao et al include a vehicle alone group without fear conditioning, a separate group of animals underwent PBS dSC/DpMe injection 2 days after preinjection startle baseline testing. As in the first behavioral experiment, postinjection startle measurements were taken 11 days after injection.
Statistical analysis
Startle response amplitude was computed by the mean startle amplitude for each rat, collapsed across the three stimulus intensities. Preinfection responses were the measures in the second matching session prior to training, while postinfection responses were the measures in the test session 11 days following surgery. Twoway ANOVA with repeated measures was applied to detect any difference in startle response, contextual freezing, and locomotor activity in a within-subject paradigm for time effects (preinfection versus postinfection or tone-alone versus light-tone), and between subjects for a treatment effect (treatment groups). The ANOVA also examined the time by group interaction. If ANOVA yielded a significance of 0.05, pair t-tests were used to assess the difference in startle amplitude between preinfection and postinfection sessions or between the tone-alone and light-tone trials, and post hoc Dunnett tests (two-sided) were used to compare the vehicle group with the virus-injected groups for differences in percent change between the pre-and postinfection or between the tone-alone and light-tone trials. Student's t-test was used to compare the startle amplitude between the AdGFP and AdLC groups over the recovery course on postinfection day 6 to day 16, and a linear trends test using GLM procedure for repeated measures was used to assess the three postinjection measures in startle for recovery.
Histology
Immediately after the postinfection test session, rats were killed with overdose of chloral hydrate and perfused intracardially with 0.9% saline followed by 8% paraformaldehyde (Sigma-Aldrich Co., St Louis, MO, USA). Brains were extracted, post-fixed overnight, and transferred to a 20% sucrose solution for 24 h. Brains were blocked and frozen in optimal cutting temperature gel (OCT: Sakura Finetek, Inc., Torrance, CA, USA) and stored at À801C. Brains were cut serially in 20 mm sections using a Jung Frigocut 2800 cryostat (Leica Microsystems, Nussloch, Germany) and mounted on precleaned superfrost plus microslides (VWR Scientific, West Chester, PA, USA). Sectioning was initiated 5 mm posterior to the optic chiasm and carried through 4 mm to a point approximately 9 mm posterior to Bregma. GFP expression was detected under a fluorescent microscope. Alternate sections were counterstained with cresyl violet in order to identify surrounding anatomical landmarks. The stereotactic location of the epicenter of GFP expression was calculated for each animal as previously described. 3 The difference between actual target and ideal target was calculated for the x, y, and z dimensions. Each of the three errors was compared using a Student's t-test.
Tissue sections were compared for qualitative differences indicative of structural damage. Next, the maximum diameter of GFP expression was determined as well as the rostro-caudal extent of GFP expression. The center of GFP expression was transcribed onto a Paxinos and Watson Atlas mapping the location of the deep SC/ DpMe (6.8 mm posterior to Bregma) to evaluate the targeting of AdLC injections.
Immunohistochemistry
Tissue sections identified as having GFP expression were washed thoroughly with PBS and permiated with PBSTriton X 100 for 10 min at room temperature (RT). Sections were blocked with 10% donkey serum in PBSTriton X 100 for 1 h. Rabbit anti-synaptobrevin primary antibody was diluted 1:50 in blocking solution and applied to sections in a humid chamber on a shaker for 72 h at 41C. Negative controls were performed by applying blocking solution alone, and incubating them in an identical fashion. Slides were washed for 2-3 min, 10-12 times prior to applying the secondary antibody. Biotinylated donkey anti-rabbit IgG was diluted 1:200 in blocking buffer and incubated at RT for 45 min. Slides were washed and rinsed with bicarbonate-buffered saline. Streptavedin-rhodamine complex was applied at a 1:500 dilution for 30 min at RT. Slides were washed and coverslipped with Gel/Mount (Biomeda, Foster City, CA, USA). Confocal microscopy was utilized to image GFP and rhodamine in the green and red spectra.
Quantitative VAMP Western blot
Two rats underwent unilateral dSC/DpMe injection with AdLC and two rats underwent unilateral AdGFP injection. At 11 days after injection, rats were perfused intracardially with cold 0.9% saline and the brains were removed and snap frozen in cold 2-methylbutane inside dry ice. Brains were cut serially in 20 mm sections in a cryostat and mounted on microslides. GFP-expressing tissues of both AdLC and AdGFP rats were microdissected under a fluorescent microscope. Tissue from the identical location on the contralateral side without GFP expression was used as control samples. Samples were loaded on a 15% Tris-HCl Gel (Bio-Rad Laboratories, CA, USA) and electrophoresed for the separation of proteins by SDS-PAGE.
Proteins were transferred on a polyvinylidene fluoride (PVDF) microporous membrane (Millipore Corporation, MA, USA) and probed with an antibody against synaptobrevin (VAMP-1/2) protein (1:200 dilution) and with goat anti-rabbit IgG-HRP (1:2000 dilution, Santa Cruz Biotechnology, CA, USA). The blot was stripped and reprobed with an antibody against b-actin as a protein loading control. Experimental design therefore allowed for a comparison of treated and untreated dSC/ DpMe in AdGFP and AdLC animals. 
